August 2014—A Proteinase–3 (cANCA) native autoantigen for the in vitro diagnostics market is available from The Binding Site. Expressly designed for use as an integral component in solid-phase, ELISA-based immunoassay test procedures, the Proteinase–3 (cANCA) native autoantigen is for clinical and life-science researchers, medical laboratory professionals, and manufacturers of in vitro diagnostic immunoassay kits and tests for autoimmune conditions.
Derived and sourced from human neutrophils and tested to be free of HBs-Ag, HCV, HIV-1, and HIV-2, this Proteinase–3 native autoantigen exhibits a purity level greater than 95 percent, as assessed by SDS gel electrophoresis, and displays high degrees of activity and specificity while demonstrating shelf-life stability and lot-to-lot consistency. It is available in two separate operator-oriented packaging formats, including 1-mg and 0.2-mg standard fill vials, with bulk packaging configurations also available.
The Binding Site, 800-633-4484